Hematology

Expert-led videos and podcasts reviewing newly approved therapies in hematology, with discussion of clinical trial data, mechanisms of action, and implications for patient management.

Teclistamab Plus Daratumumab Approved for Relapsed or Refractory Multiple Myeloma After MajesTEC-3

Luciano Costa, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

AQUILA Trial Insights: Daratumumab for the Treatment of High-Risk Smoldering Myeloma

S. Vincent Rajkumar, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

EPCORE FL-1: Epcoritamab Plus Lenalidomide and Rituximab for Follicular Lymphoma

Gilles Salles, MD, PhD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

KOMET-001 Leads to Ziftomenib Approval for NPM1-Mutated AML

Eunice Wang, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD